Sort
48,018 grants matching “immunotherapy”
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,008,673Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,008,673Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,008,580Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Costimulation blockade, chimerism and tolerance across varying degrees of MHC dis
$1,008,525Christian P Larsen · Emory University · U19 · FY2009 · AI
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$1,007,904William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$1,007,876William C Hahn · Dana-Farber Cancer Inst · U01 · FY2018 · CA
PEDIATRIC AIDS CLINICAL TRIALS UNIT
$1,007,797New York University School Of Medicine · U01 · FY2000 · AI
Targeting intratumor heterogeneity in breast cancer
$1,007,771Kornelia Polyak · Dana-Farber Cancer Inst · R35 · FY2024 · CA
The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center
$1,007,637William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Autoimmunity: Mechanisms of Unresponsiveness
$1,007,289Charles Garrison Fathman · Stanford University · P01 · FY2006 · AI
SPECT/CT Imaging of Systemic AA-Amyloidosis in Mice
$1,007,249University Of Tennessee Knoxville · R01 · FY2002 · EB
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
$1,007,233Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2021 · CA
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
$1,007,233Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2020 · CA
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
$1,007,233Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2018 · CA
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
$1,007,233Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2017 · CA
Cancer-cell specific therapy: photo-immunotherapy
$1,006,345Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Chimpanzee Biomedical Research Program Limited Competition (U42)
$1,006,169M. Babette Fontenot · University Of Louisiana At Lafayette · U42 · FY2013 · OD
Humanized Mouse Avatars for T1D
$1,005,973Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · U01 · FY2022 · DK
Modeling the ecology of tissue-resident T cells
$1,005,945Andrew Yates · Columbia University Health Sciences · U01 · FY2023 · AI
Pig-to-Monkey Islet Xenotransplantation
$1,005,885Bernhard Josef Hering · University Of Minnesota · U01 · FY2015 · AI
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,005,764Pablo Tamayo · University Of California, San Diego · U01 · FY2020 · CA
Analysis and Modulation of Virus-Host Interaction in Infections of the Liver
$1,005,702Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers
$1,005,360Andrew J. Gentles · Stanford University · U01 · FY2025 · CA
Basic Research Support for the CCR
$1,005,224Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Passive Immunotherapy for Pediatric Mutans Streptococcal Infections
$1,005,197Martin A Taubman · Ada Forsyth Institute, Inc. · R56 · FY2009 · DE